MadeHere Med
A verified B2B marketplace that lets US hospitals discover, qualify, and order from domestic and allied-nation medical-glove and PPE manufacturers with audited capacity and lead times.
US hospital procurement teams actively seeking domestic or allied PPE suppliers
- Audited directory of FDA-registered US and allied PPE makers with verified monthly capacity, not just brochures
- Standardized spec sheets, lead-time quotes, and minimum-order quantities so hospitals don't spend months in email back-and-forth
- Group-purchasing option that pools orders from smaller hospitals to hit domestic makers' MOQs
- Public 'MadeHere' verification badge backed by third-party mill audits
The HN thread made clear that even after $1B in federal funding, US hospitals still cannot find a domestic glove supplier they can actually buy from; sourcing, not just risk-scoring, is the pain point.
Bloomberg/HN coverage confirms hospitals genuinely struggle to source domestic gloves after ~$1B federal push, and US Medical Glove Co is scaling from 2.5B to ~5B gloves/year, indicating real buyer demand — but the underlying supply constraint (not just discovery) caps how much a marketplace can convert.Almost $1 Billion Later, the US Still Can't Make a Medical Glove ↗How U.S. Medical Glove Company Is Reindustrializing American Manufacturing ↗
AHRMM (the healthcare supply chain association) already runs a Domestic Manufacturers Directory, major GPOs (Vizient, Premier, HealthTrust) handle qualification+contracts, and adjacent players like Project N95 and Canada's CMMA occupy the verified-PPE-mediator niche, leaving a narrow lane.Domestic Manufacturers Directory | AHRMM ↗CMMA | Canadian Medical Manufacturers Association ↗
Hospital procurement runs on long GPO contracts with thin admin fees (~1-3%); a marketplace must either take a transaction cut from very few suppliers or charge qualification SaaS to manufacturers, but displacing entrenched GPO relationships is hard.Reducing Hospital Procurement Costs Through Vendor Contract Management ↗Why Supply Chain Leaders Trust GPO Partnerships ↗
Reshoring PPE is bipartisan, post-COVID supply-chain resilience is now institutional, and federal Buy American / BARDA / DHHS mandates create a durable policy tailwind that outlasts any single administration.
Auditing real capacity and lead times requires costly on-site visits, FDA registration and ASTM compliance validation, and the supplier pool is genuinely tiny (US Medical Glove Co is one of the only scaled players), creating a hard cold-start on both sides.